期刊文献+

冠心病患者服药依从性的研究进展 被引量:5

Advances in Medication Adherence of Patients with Coronary Heart Disease
下载PDF
导出
摘要 冠心病二级预防药物是冠心病防治工作的基础,而服药依从性是影响治疗结局的主要因素之一,现对冠心病患者服药依从性的定义、现状、影响因素、测量方法、改善对策,以及存在的问题及展望等做一综述,为临床工作提供帮助。 The secondary prevention of coronary heart disease( CHD) is the basis for prevention and treatment of CHD,however,a patient's adherence to their medication adherence is one of the main factors that affecting treatment outcome. This paper reviewed the definition,present situation,influencing factors,measurement methods,improvement methods and the problems and prospects of this field,in order to provide some help for clinical work.
作者 陈静 李兴德
出处 《心血管病学进展》 CAS 2015年第6期728-731,共4页 Advances in Cardiovascular Diseases
关键词 冠心病 二级预防 服药依从性 coronary heart disease secondary prevention medication adherence
  • 相关文献

参考文献24

  • 1Jiang G,Wang D, Li W,et al. Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition [ J ]. Rev Panam Salud Publica,2012,31 (4) :317-324.
  • 2Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Preven- tion and Risk Reduction Therapy for Patients with Coronary and other Athero- sclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation [ J ]. Circulation, 2011,124(22) :2458-2473.
  • 3Choudhry NK, Glynn R J, Avoru J, et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes : medication ad- herence and clinical outcomes[ J]. Am Heart J ,2014,167( 1 ) :51-58.
  • 4Ho PM, Bryson CL, Rumsfeld JS. Medication adherence :its importance in car- diovascular outcomes [ J ]. Circulation,2009,119 ( 23 ) : 3028 -3035.
  • 5Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular thera- py : a meta-analysis of prevalence and clinical consequences [ J ]. Eur Heart J, 2013,34(38) : 2940-2948.
  • 6Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for car- diovascular disease in the community in high-income, middle-income, and low- income countries (the PURE study) :a prospective epidemiological survey [ J ]. Lancet,20l 1,378 (9798) : 1231-1243.
  • 7Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovas- cular disease: meta-analysis on 376 162 patients [ J ]. Am J Med, 2012, 125 (9) :882-887.
  • 8Rossi E,Perman G, Michelangelo H, et al. Medication adherence to secondary prevention for coronary artery disease [ J ]. Medicina ( B Aires), 2014,74 ( 2 ) : 99-103.
  • 9Valle JA, Ho PM. Medication adherence in secondary prevention post-myocardi- al infarction[J]. Curr Treat Options Cardiovasc Med,2014,16(12) :349.
  • 10Wroe AL. Intentional and Unintentional nonadherence : a study of decision-mak- ing[J]. J Behav Med,2002,25(4) :355-372.

同被引文献28

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部